PanGen Biotech Inc Capital Reinvestment Ratio

Latest as of June 2025: 0.02x

PanGen Biotech Inc capital reinvestment ratio. PanGen Biotech Inc (222110) has a Capital Reinvestment Ratio of 0.02x as of June 2025, meaning it reinvests 0% of its operating cash flow (₩3.22 Billion) in capital expenditures (₩56.30 Million). Check 222110 total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.02x
Capex / Operating Cash Flow

Operating Cash Flow

₩3.22 Billion
KRW

Capital Expenditures

₩56.30 Million
KRW

Data as of

Jun 2025
Most recent filing

Capital Reinvestment Ratio of PanGen Biotech Inc (2024–2024)

Capital reinvestment ratio of PanGen Biotech Inc from 2024 to 2024. This chart tracks PanGen Biotech Inc's Capital Reinvestment Ratio across 1 annual periods. Also explore how fast is PanGen Biotech Inc growing its equity to track the company's year-over-year net asset growth rate.

PanGen Biotech Inc Capital Reinvestment Ratio by Year (2024–2024)

PanGen Biotech Inc capital reinvestment ratio by year from 2024 to 2024. For the full cash flow conversion analysis, see cash efficiency ratio of PanGen Biotech Inc.

Year Reinvestment Ratio Operating CF (KRW) Capital Expenditures YoY Change
2024 0.13x ₩2.99 Billion ₩374.12 Million —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow